Clinical Value of Vestibular Evoked Myogenic Potential in Assessing the Stage and Predicting the Hearing Results in Ménière’s Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. Our goal was to find the clinical value of cervical vestibular evoked myogenic potential (VEMP) in Ménière’s disease (MD) and to evaluate whether the VEMP results can be useful in assessing the stage of MD. Furthermore, we tried to evaluate the clinical effectiveness of VEMP in predicting hearing outcomes. Methods. The amplitude, peak latency and interaural amplitude difference (IAD) ratio were obtained using cervical VEMP. The VEMP results of MD were compared with those of normal subjects, and the MD stages were compared with the IAD ratio. Finally, the hearing changes were analyzed according to their VEMP results. Results. In clinically definite unilateral MD (n=41), the prevalence of cervical VEMP abnormality in the IAD ratio was 34.1%. When compared with normal subjects (n=33), the VEMP profile of MD patients showed a low amplitude and a similar latency. The mean IAD ratio in MD was 23%, which was significantly different from that of normal subjects (P=0.01). As the stage increased, the IAD ratio significantly increased (P=0.09). After stratification by initial hearing level,stage I and II subjects (hearing threshold, 0-40 dB) with an abnormal IAD ratio showed a decrease in hearing over time compared to those with a normal IAD ratio (P=0.08). Conclusion. VEMP parameters have an important clinical role in MD. Especially, the IAD ratio can be used to assess the stage of MD. An abnormal IAD ratio may be used as a predictor of poor hearing outcomes in subjects with early stage MD.
Abstract
Objectives. Our goal was to find the clinical value of cervical vestibular evoked myogenic potential (VEMP) in Ménière’s disease (MD) and to evaluate whether the VEMP results can be useful in assessing the stage of MD. Furthermore, we tried to evaluate the clinical effectiveness of VEMP in predicting hearing outcomes. Methods. The amplitude, peak latency and interaural amplitude difference (IAD) ratio were obtained using cervical VEMP. The VEMP results of MD were compared with those of normal subjects, and the MD stages were compared with the IAD ratio. Finally, the hearing changes were analyzed according to their VEMP results. Results. In clinically definite unilateral MD (n=41), the prevalence of cervical VEMP abnormality in the IAD ratio was 34.1%. When compared with normal subjects (n=33), the VEMP profile of MD patients showed a low amplitude and a similar latency. The mean IAD ratio in MD was 23%, which was significantly different from that of normal subjects (P=0.01). As the stage increased, the IAD ratio significantly increased (P=0.09). After stratification by initial hearing level,stage I and II subjects (hearing threshold, 0-40 dB) with an abnormal IAD ratio showed a decrease in hearing over time compared to those with a normal IAD ratio (P=0.08). Conclusion. VEMP parameters have an important clinical role in MD. Especially, the IAD ratio can be used to assess the stage of MD. An abnormal IAD ratio may be used as a predictor of poor hearing outcomes in subjects with early stage MD.
참고문헌 (24)
- da Costa SS, "Meniere’s disease: overview, epidemiology, and natural history", Otolaryngol Clin North Am, 35(3), pp.455~495 (2002)
- Okuno T, "Localization, frequency, and severity of endolymphatic hydrops and the pathology of the labyrinthine membrane in Menière’s disease", Ann Otol Rhinol Laryngol, 96(4), pp.438~445 (1987)
- Schuknecht HF, "Endolymphatic hydrops: an overview and classification", Ann Otol Rhinol Laryngol Suppl, 106, pp.1~20 (1983)
- Paparella MM, "The cause (multifactorial inheritance) and pathogenesis (endolymphatic malabsorption) of Meniere’s disease and its symptoms (mechanical and chemical)", Acta Otolaryngol, 99(3-4), pp.445~451 (1985)
- Merchant SN, "Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops?", Otol Neurotol, 26(1), pp.74~81 (2005)
- "Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc", Otolaryngol Head Neck Surg, 113(3), pp.181~185 (1995)
- Enander A, "Hearing loss and caloric response in Menière’s disease: a comparative study", Acta Otolaryngol, 67(1), pp.57~68 (1969)
- de Waele C, "Saccular dysfunction in Meniere’s disease", Am J Otol, 20(2), pp.223~232 (1999)
- Igarashi M, "Utricular and saccular volumetry in human temporal bones", Acta Otolaryngol, 95(1-2), pp.75~80 (1983)
- Moon IJ, "Predictive value of electrocochleography for determining hearing outcomes in Ménière’s disease", Otol Neurotol, 33(2), pp.204~210 (2012)
- Colebatch JG, "Myogenic potentials generated by a click-evoked vestibulocollic reflex", J Neurol Neurosurg Psychiatry, 57(2), pp.190~197 (1994)
- Young YH, "Assessing the stage of Meniere’s disease using vestibular evoked myogenic potentials", Arch Otolaryngol Head Neck Surg, 129(8), pp.815~818 (2003)
- Murofushi T, "Glycerol affects vestibular evoked myogenic potentials in Meniere’s disease", Auris Nasus Larynx, 28(3), pp.205~208 (2001)
- Rauch SD, "Vestibular evoked myogenic potentials show altered tuning in patients with Ménière’s disease", Otol Neurotol, 25(3), pp.333~338 (2004)
- Murofushi T, "Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential", Arch Otolaryngol Head Neck Surg, 127(9), pp.1069~1072 (2001)
- Ribeiro S, "Vestibular evoked myogenic potentials in affected and asymptomatic ears in unilateral Ménière’s disease", Braz J Otorhinolaryngol, 71(1), pp.60~66 (2005)
- Chang CH, "Measuring neck structures in relation to vestibular evoked myogenic potentials", Clin Neurophysiol, 118(5), pp.1105~1109 (2007)
- Altmann F, "Histological studies of Menière’s disease", Ann Otol Rhinol Laryngol, 74(4), pp.915~943 (1965)
- Hallpike CS, "Observations on the pathology of Ménière’s syndrome: section of otology", Proc R Soc Med, 31(11), pp.1317~1336 (1938)
- Huppert D, "Long-term course of Menière’s disease revisited", Acta Otolaryngol, 130(6), pp.644~651 (2010)
- Green JD Jr, "Longitudinal followup of patients with Menière’s disease", Otolaryngol Head Neck Surg, 104(6), pp.783~788 (1991)
- Katsarkas A, "Hearing loss and vestibular dysfunction in Menière’s disease", Acta Otolaryngol, 116(2), pp.185~188 (1996)
- Stahle J, "Long-term progression of Meniére’s disease", Acta Otolaryngol Suppl, 485, pp.78~83 (1991)
- Tokumasu K, "Initial symptoms and retrospective evaluation of prognosis in Menière’s disease", Acta Otolaryngol Suppl, 524, pp.43~49 (1996)